Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert W Robey

Showing results (21-30 of 122) with videos related to

Pageof 13
Sort By:
Cancer Research|September 5, 2002
Overexpression of wild-type breast cancer resistance protein mediates methotrexate resistanceErin L Volk, Kate M Farley, Yan Wu, et al.
Cell Cycle (Georgetown, Tex.)|April 17, 2008
Proteasome inhibitors increase tubulin polymerization and stabilization in tissue culture cells: a possible mechanism contributing to peripheral neuropathy and cellular toxicity following proteasome inhibitionMarianne S Poruchynsky, Dan L Sackett, Robert W Robey, et al.
Molecular Cancer Therapeutics|October 15, 2009
Escape from hsa-miR-519c enables drug-resistant cells to maintain high expression of ABCG2Kenneth K W To, Robert W Robey, Turid Knutsen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 15, 2006
Increased MDR1 expression in normal and malignant peripheral blood mononuclear cells obtained from patients receiving depsipeptide (FR901228, FK228, NSC630176)Robert W Robey, Zhirong Zhan, Richard L Piekarz, et al.
Cancer Research|February 20, 2004
Pheophorbide a is a specific probe for ABCG2 function and inhibitionRobert W Robey, Kenneth Steadman, Orsolya Polgar, et al.
Biochemical and Biophysical Research Communications|November 27, 2008
ABCG2 is expressed in late spermatogenesis and is associated with the acrosomeChristian Scharenberg, Nadja Mannowetz, Robert W Robey, et al.
Molecular Pharmaceutics|September 9, 2011
Histone deacetylase inhibitors: emerging mechanisms of resistanceRobert W Robey, Arup R Chakraborty, Agnes Basseville, et al.
Cancer Letters|May 10, 2019
Porphyrin-lipid assemblies and nanovesicles overcome ABC transporter-mediated photodynamic therapy resistance in cancer cellsYan Baglo, Barry J Liang, Robert W Robey, et al.
Cancer Biology & Therapy|March 19, 2003
Single-nucleotide polymorphism (SNP) analysis in the ABC half-transporter ABCG2 (MXR/BCRP/ABCP1)Yasumasa Honjo, Kuniaki Morisaki, Lyn Mickley Huff, et al.
Cancer Drug Resistance (Alhambra, Calif.)|July 26, 2021
ATP-binding cassette transporters at the zebrafish blood-brain barrier and the potential utility of the zebrafish as an <i>in vivo</i> modelJordan M Hotz, Joanna R Thomas, Emily N Katz, et al.
Pageof 13

Showing results (21-30 of 122) with videos related to

Sort By:
Pageof 13
Cancer Research|September 5, 2002
Overexpression of wild-type breast cancer resistance protein mediates methotrexate resistanceErin L Volk, Kate M Farley, Yan Wu, et al.
Cell Cycle (Georgetown, Tex.)|April 17, 2008
Proteasome inhibitors increase tubulin polymerization and stabilization in tissue culture cells: a possible mechanism contributing to peripheral neuropathy and cellular toxicity following proteasome inhibitionMarianne S Poruchynsky, Dan L Sackett, Robert W Robey, et al.
Molecular Cancer Therapeutics|October 15, 2009
Escape from hsa-miR-519c enables drug-resistant cells to maintain high expression of ABCG2Kenneth K W To, Robert W Robey, Turid Knutsen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 15, 2006
Increased MDR1 expression in normal and malignant peripheral blood mononuclear cells obtained from patients receiving depsipeptide (FR901228, FK228, NSC630176)Robert W Robey, Zhirong Zhan, Richard L Piekarz, et al.
Cancer Research|February 20, 2004
Pheophorbide a is a specific probe for ABCG2 function and inhibitionRobert W Robey, Kenneth Steadman, Orsolya Polgar, et al.
Biochemical and Biophysical Research Communications|November 27, 2008
ABCG2 is expressed in late spermatogenesis and is associated with the acrosomeChristian Scharenberg, Nadja Mannowetz, Robert W Robey, et al.
Molecular Pharmaceutics|September 9, 2011
Histone deacetylase inhibitors: emerging mechanisms of resistanceRobert W Robey, Arup R Chakraborty, Agnes Basseville, et al.
Cancer Letters|May 10, 2019
Porphyrin-lipid assemblies and nanovesicles overcome ABC transporter-mediated photodynamic therapy resistance in cancer cellsYan Baglo, Barry J Liang, Robert W Robey, et al.
Cancer Biology & Therapy|March 19, 2003
Single-nucleotide polymorphism (SNP) analysis in the ABC half-transporter ABCG2 (MXR/BCRP/ABCP1)Yasumasa Honjo, Kuniaki Morisaki, Lyn Mickley Huff, et al.
Cancer Drug Resistance (Alhambra, Calif.)|July 26, 2021
ATP-binding cassette transporters at the zebrafish blood-brain barrier and the potential utility of the zebrafish as an <i>in vivo</i> modelJordan M Hotz, Joanna R Thomas, Emily N Katz, et al.
Pageof 13